{"name":"TTY Biopharm","slug":"tty-biopharm","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"S-1","genericName":"S-1","slug":"s-1","indication":"Gastric cancer","status":"marketed"}]}],"pipeline":[{"name":"S-1","genericName":"S-1","slug":"s-1","phase":"marketed","mechanism":"S-1 is an oral combination of tegafur, gimeracil, and oteracil potassium that inhibits thymidylate synthase and enhances fluorouracil activity to suppress cancer cell DNA synthesis.","indications":["Gastric cancer","Colorectal cancer","Pancreatic cancer","Biliary tract cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE5yc3ZVaXl1c3FkYXk1Wi1VVXB1UF9ySktLT3l0MGlKR3BoUXdxVHYtbW9BM3JuNW1vZkd2ZlVFSVpLNXMwYkZmVFBWbVVKMnpzU05OTA?oc=5","date":"2025-09-26","type":"pipeline","source":"Taiwan News","summary":"Asia Pacific Enterprise Awards (APEA) 2025 Taiwan Honors Outstanding Leaders and Enterprises Shaping the Future of Business - Taiwan News","headline":"Asia Pacific Enterprise Awards (APEA) 2025 Taiwan Honors Outstanding Leaders and Enterprises Shaping the Future of Busin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE82eWdKc1lNQUhvZnF2U20wVnhCLXlVc01faFpjTmlGc3NCT1ExbEc0d0ZqVWV2N0VrWDItRDF2SFNZRnJOQW9INUw0Q2pKSUI1Njhnb0NybmJXZmlScTh5MncyamhDRlVWOE13cG9zVTdRdlRJUm5MaEFR?oc=5","date":"2025-02-11","type":"deal","source":"Taipei Times","summary":"Taiwan to buy 7m trivalent flu vaccines - Taipei Times","headline":"Taiwan to buy 7m trivalent flu vaccines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBqNXI5VlJZbk9UblFEckpkdk5JUDJ4Z2JSNzY1LUEyVWt0bFIwNUt3VElZWXVDb045OTl4cmF0YmVnRHBlcU5WYjFsU0x6U0dQWks0akN3OERPYkZSSU95cWtMY3ZycVFHQms4djk2SXVaTHJYVlc3cWNn?oc=5","date":"2024-08-23","type":"pipeline","source":"Taipei Times","summary":"Wu Tzu-chia charged with aggravated defamation - Taipei Times","headline":"Wu Tzu-chia charged with aggravated defamation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxON2lQczhMTDhKTVIxMUx6N1huSE14X3dPRExoRjNBSkt3VV92OTZVYk1TZDI1MUpod09acV9KcUpwT0Y3d2hMUHozYU1BcUV2OUVpdXN6ZVVEdGwzb1hWTWx1bmt0WnRUbFhoMEd1b1NZYlZSZWFVS2piaFJKSG9rZTF1YktBbXFid3U5RGpqTmZPeXdFYTBXWHdWdGNRVElkVGlBVnlvOTl4bVFjSklXWmR0MWZTUXNZZkdVT3hGR3d2LTdH?oc=5","date":"2024-03-27","type":"pipeline","source":"BioPharma APAC","summary":"Roche Taiwan Joins Forces with TTY Biopharm, Ushering in a New Dawn for Cancer Care - BioPharma APAC","headline":"Roche Taiwan Joins Forces with TTY Biopharm, Ushering in a New Dawn for Cancer Care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNZXU1Y0phNzg4LXltaTV6QWQ4ZnMtajRBQ0k1SFZRYnJrUWw5LXNNenlUUWRXSVRmelZuNnRqcGtYdjZmU3VieVl0aUtmZVlUSWNSRGEzUXdjUm9IcWNiMkJxTExfZWM2VlhoV3MyMGYxai1KdEg4OUUxX3FqVEl6VF94blU2eF9mZXN0N3NVd3hDcmc?oc=5","date":"2023-01-12","type":"earnings","source":"全球醫療採購網","summary":"Taiwan business watch 2022: Biomedical sector top 20 by revenue and segment - 全球醫療採購網","headline":"Taiwan business watch 2022: Biomedical sector top 20 by revenue and segment - 全球醫療採購網","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQSFJXUjhLTWhMWVcybzZFOWdyRGR6YmJDNV9TUy1HTllUSU56VDhTU2NMWDF6d3NoTFhqOTZyZnBweFAzMFU3ejdPdWZmTUpfWFRVYzVBeXE0TWJXeFVaSXRpOVZLbVdzMUhtZDhVbXQ2TXZYSmhud1M1V3RDSjRFb2FRakVDWUF3T3UxSmh3Q1A2TjV2VFBGSTE5TEFvbC1BRk1BdnF1dXJyLTBBQnpQb1FUMWlGY25pVk5qU3B0MzZXd0pHRzJmWE9ibVA2OUV3bnNFQjBlNNIB3AFBVV95cUxQN09XSUdmdlBKYTVCaTNzSlU3Qjl6eHc4OEgxWDNITkRPSmxpWl9VVjVMdVhPbGQteUhpanZLcXdzdXhSbjlTcUlwbTdpeVNqRFFUeUNJT1M0cmZWQlp1bGFmNlhERWhLbTBHVEVpUnJVbERfNlFZYk1kT3liVkJJTmtIRWJmQU1ReGZVQVMzNHA1WFN5bXRQel92Z2tqVS1ndDdESTVYeHYyb25acWVWdV9ZZUhyTU13VGg5OGRMZ21PRDJKdmdWWXBFa0Z3eHFUdldVWE9sWjBhRDU5?oc=5","date":"2022-11-18","type":"regulatory","source":"Medical Dialogues","summary":"Aurobindo Pharma subsidiary bags USFDA nod for Amphotericin B Liposome for Injection - Medical Dialogues","headline":"Aurobindo Pharma subsidiary bags USFDA nod for Amphotericin B Liposome for Injection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOeW03R2NiMTZJMnhNZlVTMkVfRHUtSzVYUmtZTUxiR1JrdFVObGotRmlpUmhFWWgyT3Rnd0tNMkhFNVJBYlVnd3ZOLWliWEN2X0FzLTMzNHZ2Zmh2OUU4MTExaU5wd3VKM3dDVE1rbDdmUWlRRnQydGh5VU1mNjNOdDM1QXVUTmQ2WS1QUzBHQ3NFZjhRZktUYmVjOXlNUU5sX09XNEcwbHdOenFUNFhSSzF4UEVGUEFOOXdwQVdaOS1fR3hkV0ltT3dacGpZU3pW?oc=5","date":"2022-11-18","type":"regulatory","source":"India Infoline","summary":"Aurobindo Pharma's arm Eugia Pharma gets USFDA approval for Amphotericin B Liposome for Injection - India Infoline","headline":"Aurobindo Pharma's arm Eugia Pharma gets USFDA approval for Amphotericin B Liposome for Injection","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOdm55YVB0YTdKc29JMDF4aDF3bVdEV1hEN3FZWWVUbTJ5X0xJTXgwMEwzWWxNaFp5ZjBpNWFyZ3ZxYzhEYTJHdGE2YjBJc3Q4akRraTVHNkZHYWRFb0VNSEFlMlpmdktUMl9Kc0owTlkyLUJTSGFmZXpXc1huNFJYUl9UM1B0T1UxZkZFWmlKUXpLUVE0TzY4ZVJ3WjY5c3ZxNFQ5dEZlTkVTekg0?oc=5","date":"2021-08-02","type":"pipeline","source":"全球醫療採購網","summary":"Taiwan’s biotechnology and pharmaceutical sectors join hands in the post-COVID economy - 全球醫療採購網","headline":"Taiwan’s biotechnology and pharmaceutical sectors join hands in the post-COVID economy - 全球醫療採購網","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE04ZVp3T1NNSzNQUzNkUzZvVmlXTzBXTzZCV3d5V3lGUjQwMTN1MGZxTktxakdoajNybW5zN2M0al80ZWFjUXFUZ0dmTnlZbHo0VlRkUFZpZ2RBNDBDY0RTbWV1WjFfWERsVE01OHJjN2M3TGtFaFg1LTh3?oc=5","date":"2021-01-20","type":"regulatory","source":"Taipei Times","summary":"FDA recalls 9,000 vials of cancer medicine Gemmis - Taipei Times","headline":"FDA recalls 9,000 vials of cancer medicine Gemmis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBXcURSaXVPcTlySnliUjl5MFluZlFfaU55RmVVWEFHSlBGNFM0V3ZCQkIyQW5Ca0NBNDBWQ0xDSndDdnNHZUVkOW85dDlnX2NyQm1ndHRxUHV4QmhTbVJZalJXRFVlcExLT3ZyR0lnb3FrU21wR2c?oc=5","date":"2020-11-13","type":"pipeline","source":"Taipei Times","summary":"TTY Biopharm Co denies allegations of insider trading - Taipei Times","headline":"TTY Biopharm Co denies allegations of insider trading","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBla1QtNUdYX0g2VkRoMG83WE5JZU9JLWFMaWR6b2NNRkRTZnd5RkVWY2hnUlhMbzlPN2JIS0s2cUJlbk5wUXAzZUVEMDRMNEpleTZ6SjdHVXlnNklLSlQzT1pnOG1nN3c?oc=5","date":"2020-10-30","type":"pipeline","source":"天下雜誌","summary":"The Hard Truth About How Korean Biotech Surpassed Taiwan｜Industry｜2020-10-30 - 天下雜誌","headline":"The Hard Truth About How Korean Biotech Surpassed Taiwan｜Industry｜2020-10-30 - 天下雜誌","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFBvYkRJYzhwT25fQW9GU1FzUU1fSHFfTFZuWm9sSXVCSjZRd0RSRk51VWMzMU5BRUhRdjVKamlwdldnM3ZaSzJxcFg4UzR1VldvR3JkV1ZHSQ?oc=5","date":"2017-09-08","type":"pipeline","source":"sg.finance.yahoo.com","summary":"Orient EuroPharma Co., Ltd. (4120.TWO) stock price, news, quote and history - sg.finance.yahoo.com","headline":"Orient EuroPharma Co., Ltd. (4120.TWO) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}